Den förvaltande delen av bolaget fortsätter att leverera Hyresintäkterna i kvartalet uppgick till 1 ...
Redeye endorses today’s news that the independent Data and Safety Monitoring Board (DSMB) for the Pi...
• Q2 report due on Thursday, 27 July • Some but not full effect from cost savings programme • Tradin...
• DSMB recommends Pirepemat Ph 2b study to continue • Recommendation based on safety analysis of 25 ...
This morning, Vow announced that the company’s record USD 27m contract for a Biochar/renewable energ...
Redeye has a neutral stance on Episurf Medical’s Q2 report as sales have yet to take off.
APAC and Consumables delivers another strong quarter with double digit growth.
Redeye observes that Doro's Q2 2023 sales were consistent with our projections, with a beneficial cu...
Redeye retains its positive view of Formpipe following a Q2 report largely matching our expectations...
Despite raising our forecasts slightly, Redeye leaves its Base Case unchanged at levels close to whe...
Redeye remains confident on the case although Q2 numbers were a bit below our estimates.
• Q2: Soft sales hit profitability • Orders needed to add confidence to 2025 targets • Estimates dow...
Redeye gives a short comment on Ependion's Q2 2023, which came in exactly in line on EBIT, and close...
• Sales -1-2% as we estimate neg. organic growth in Q3-Q4e • Cost reduction programme makes us raise...
Plejds nettoomsättning för det andra kvartalet 2023 uppgick till 110,3 MSEK, en ökning med 3,7 % y-o...
• -2% organic growth (ABGe 3%) amid tough comps • Adj.
Redeye is encouraged by the third consecutive positive quarterly report from Tagmaster.
Svag utrullning av stadsnätskunder i Norden utanför Sverige i Q2’23 Waystream rapporterade ett svagt...
Redeye sees a Q2 report in line with what we expected following the preliminary figures.
Redeye expected stronger Q2 numbers from Powercell, mainly in terms of sales growth.
